Sulfasalazine is a medication used to treat two main conditions: ulcerative colitis and rheumatoid arthritis. Sold under the brand name Azulfidine, it works by reducing inflammation in the gut and joints. It has been available for decades and remains a common choice for managing these conditions in both adults and children.
Ulcerative Colitis
Sulfasalazine’s primary use is treating mild to moderate ulcerative colitis, a type of inflammatory bowel disease that causes sores and inflammation in the lining of the large intestine. It can also be used alongside other treatments in severe cases. Beyond controlling active flares, it plays an important role in maintenance therapy, helping to extend the quiet periods between flare-ups and keep symptoms in remission long term.
Rheumatoid Arthritis
The delayed-release (enteric-coated) form of sulfasalazine is approved for rheumatoid arthritis in adults who haven’t gotten enough relief from standard anti-inflammatory painkillers like ibuprofen or naproxen. It’s also approved for children with polyarticular juvenile rheumatoid arthritis, a form that affects five or more joints, when those same painkillers haven’t been sufficient.
Sulfasalazine is classified as a disease-modifying antirheumatic drug (DMARD), meaning it doesn’t just mask pain. It slows the underlying disease process that damages joints over time. However, it works gradually. Most people need 2 to 3 months of consistent use before noticing meaningful improvement in joint pain and stiffness.
How It Works in the Body
Sulfasalazine is actually a prodrug, meaning it isn’t fully active until your body breaks it down. When you swallow it, most of the tablet passes through your stomach and small intestine intact. Once it reaches the colon, bacteria there split it into two components: one that fights inflammation in the gut lining (the therapeutically active piece for colitis) and sulfapyridine, which is largely responsible for the medication’s side effects.
This design is intentional. The drug delivers its active ingredient directly to the colon, right where the inflammation lives in ulcerative colitis. For rheumatoid arthritis, the anti-inflammatory and immune-modulating effects appear to work through a broader mechanism once both components are absorbed into the bloodstream.
Common Side Effects
Digestive symptoms are the most frequent complaint. In ulcerative colitis patients, about one-third experience loss of appetite, nausea, vomiting, headache, or stomach discomfort. In rheumatoid arthritis trials, the numbers break down more specifically: nausea affected 19% of patients, indigestion 13%, rash 13%, headache 9%, abdominal pain 8%, and vomiting 8%. Fever, dizziness, mouth sores, and itching each occurred in 4 to 5% of patients.
Starting at a lower dose and gradually increasing it can help your body adjust and reduce these early side effects. Taking the medication with food also helps. Many people find that side effects ease after the first few weeks.
Blood Monitoring During Treatment
Sulfasalazine can occasionally affect blood cell counts and liver function, so regular blood tests are part of the treatment plan. When you first start or change your dose, expect blood work every two weeks until you’ve been on a stable dose for about six weeks, then monthly for the next three months. Once everything looks steady, testing typically moves to at least every 12 weeks during the first year. These tests check your blood cell counts, liver enzymes, kidney function, and a protein called albumin.
Effects on Fertility and Pregnancy
Sulfasalazine can temporarily lower sperm count in men. This is a well-known effect, and it typically reverses within 2 to 3 months after stopping the medication. If you’re a man whose partner hasn’t conceived after 12 months of trying, it’s worth discussing a switch to an alternative medication. There’s no evidence that sulfasalazine affects fertility in women.
The medication can be used during pregnancy, but because it interferes with folic acid absorption, supplementation is important. The recommended approach is taking a high-dose folic acid supplement (5 mg daily) for at least three months before trying to conceive and continuing through at least the first 12 weeks of pregnancy. This is significantly more than the standard prenatal folic acid dose, so it needs to be prescribed specifically.
What to Expect When Starting Treatment
For ulcerative colitis, treatment usually begins at a lower dose (1 to 2 grams daily) to minimize stomach upset, then increases to a therapeutic dose of 3 to 4 grams daily split into multiple doses taken no more than eight hours apart. Once symptoms are under control, the maintenance dose drops to around 2 grams daily. Children six and older are dosed based on body weight.
For rheumatoid arthritis, the starting dose is lower, typically 500 to 1,000 mg per day, increasing gradually. The maximum is 3,000 mg daily. Because it takes 2 to 3 months to reach full effectiveness for joint symptoms, your doctor may keep you on other pain-relief medications during that initial period. The delayed-release tablet form is specifically designed for arthritis use, as the enteric coating reduces stomach irritation from the higher, sustained doses these patients need.
One harmless but sometimes alarming side effect: sulfasalazine can turn your urine and skin a yellowish-orange color. This is normal and not a sign of a problem.